SME Instrument statistics

Size: px

Start display at page:

Download "SME Instrument statistics"

Adele Lester
9 years ago
Views:

1 SME Instrument statistics 0 beneficiaries Phase (June Sep 0), Phase (Oct 0) status January 0 SME Instrument (Horizon 00) DCC MANAGEMENT 0

2 SME Instrument Phase (Jun 0) beneficiaries Country breakdown Out of the 666 projects submitted (60 eligible), a number of proposals (.96%) have been selected for funding after the first round of Phase. Spain leads the way with highest no. of beneficiaries with 9, followed by UK and Italy, with 6 and 0 respectively. Phase beneficiaries (June 0) country breakdown AT DK EE FI FR DE HU IE IL IT LT NL NO PL PT SI ES SE TR UK Corporate finance services DCC MANAGEMENT 0

of beneficiaries with 9, followed by UK and Italy, with 6 and 0 respectively.

3 SME Instrument Phase (Jun 0) beneficiaries Topic breakdown With 0 projects approved for funding, Open Disruptive Innovation has the highest number of beneficiaries, after having the highest number of proposals as well (lowest success rate with.9%). With 6 and approvals, Green Transport and Clinical registered the nd and rd highest success rates with around.%) Phase beneficiaries (June 0) topic breakdown Eco Innovation and sustainable raw material supply 6 Nanotech, or other advanced tech for manufacturing and materials Clinical research for the validation of diagnosis and biomakers 6 0 Corporate finance services DCC MANAGEMENT 0

With 6 and approvals, Green Transport and Clinical registered the nd and rd highest success rates with around.

4 SME Instrument Phase (Jun 0) success rate Topic breakdown The success rate per topic is calculated as a ratio between the no. of approved projects and total no of application per topic. This should consider though the budget allocation behind every topic which varies depending on the topic. Open Disruptive Innovation will typically have lowest success rates because of the highest no of applications it attracts. Phase success rate (June 0) topic breakdown.% Eco Innovation and sustainable raw material supply.%.%.98% 6.%.9% Nanotech, or other advanced tech for manufacturing and materials.% 6.8% Clinical research for the validation of diagnosis and biomakers.%.%.9% Corporate finance services DCC MANAGEMENT 0

Open Disruptive Innovation will typically have lowest success rates because of the highest no of applications it attracts. Phase success rate (June 0) topic breakdown.

5 SME Instrument Phase (Sep 0) beneficiaries Country breakdown Out of 9 proposals totally received, 8 projects have been selected for funding (99 applicants from countries). Each beneficiary will thus receive EUR for feasibility studies. Spain, Italy and UK still are again on the podium, with Italy leading the winning group. 0 0 Phase beneficiaries (September 0) country breakdown AT DK EE FI FR DE HU IE IL IT LT NL NO PT SI ES SE TR UK BE EL LV IS RS CZ Corporate finance services DCC MANAGEMENT 0

Spain, Italy and UK still are again on the podium, with Italy leading the winning group.

6 SME Instrument Phase (Sep 0) beneficiaries Topic breakdown The topic breakdown brings no changes about the preference in topic orientation, the Open Disruptive Innovation one attracting the most bids, seeming to be the most accessible in terms of topic compliance Phase beneficiaries (September 0) topic breakdown 9 Eco Innovation and sustainable raw material supply 9 Nanotech, or other advanced tech for manufacturing and materials Clinical research for the validation of diagnosis and biomakers Corporate finance services DCC MANAGEMENT 0 6

compliance Phase beneficiaries (September 0) topic breakdown 9 Eco Innovation and sustainable raw material supply 9 Nanotech, or other

7 SME Instrument Phase (Sep 0) success rate Topic breakdown Open Disruptive Innovation shows the lowest success rates because of the highest no of applications it attracts. The second round of Phase beneficiaries shows a more compact set of success rates (compared to the first round in June 0), due to a more balanced no of applications submitted for the available topics. Phase success rate (September 0) topic breakdown.0%.% 9.0% Eco Innovation and sustainable raw material supply 9.% 0.00%.89%.69% Nanotech, or other advanced tech for manufacturing and materials 8.9% Clinical research for the validation of diagnosis and biomakers.6%.% 6.9% Corporate finance services DCC MANAGEMENT 0

submitted for the available topics. Phase success rate (September 0) topic breakdown.0%.% 9.0% Eco Innovation and sustainable raw material supply 9.% 0.00%.89%.

8 SME Instrument Phase (Jun+Sep0) beneficiaries Country breakdown The September 0 Phase round has brought beneficiaries from new countries Belgium, Greece, Latvia, Iceland, Serbia and Czech Republic compared to the June round. Nevertheless, the overall podium after first rounds of Phase 0 reflects a skewed result with three countries Spain, Italy and the UK accounting for almost half of the successful projects, with winning proposals out of the total. Total no. of Phase beneficiaries (June + September 0) country breakdown AT DK EE FI FR DE HU IE IL IT LT NL NO PL PT SI ES SE TR UK BE EL LV IS RS CZ Corporate finance services DCC MANAGEMENT 0 8

Nevertheless, the overall podium after first rounds of Phase 0 reflects a skewed result with three countries Spain, Italy and the UK accounting for almost half of

9 SME Instrument Phase (Sep 0) beneficiaries Topic breakdown All together after rounds pf SME Instrument Phase the Open Disruptive Innovation is the topic attracting the most applications, with and Greener integrated transport being nd and rd. Biotechnology and Blue Growth have attracted the least applications so far. Phase beneficiaries (June + September 0) topic breakdown 6 Eco Innovation and sustainable raw material 8 Nanotech, or other advanced tech for 8 Clinical research for the validation of diagnosis 0 Corporate finance services DCC MANAGEMENT 0 9

Biotechnology and Blue Growth have attracted the least applications so far.

10 SME Instrument Phase (October 0) beneficiaries Country breakdown Out of the 80 project proposals received at the first round of Phase (October 0), 8 SMEs from 8 countries have been selected to each receive a grant up to EUR. million (EUR million for health projects) to finance innovation activities and the development of their business plans. Spain was the leading country in number of beneficiaries, while the UK companies have actually received the highest grant amount over EUR million for 0 companies. They are followed closely by Netherlands and France. Phase beneficiaries (October 0) country breakdown AT DK EE FI FR DE HU IE IL IT LT NL NO PL PT SI ES SE TR UK BE LU Corporate finance services DCC MANAGEMENT 0 0

Spain was the leading country in number of beneficiaries, while the UK companies have actually received the highest grant amount over EUR million for 0 companies.

11 SME Instrument Phase (October 0) beneficiaries Topic breakdown As in the case of Phase projects, the Open Disruptive Innovation topic attracted the highest number of applications, resulting in the highest number of beneficiaries. It was followed by Greener and more integrated transport, and Clinical research. Phase beneficiaries (October 0) topic breakdown Eco Innovation and sustainable raw material supply Nanotech, or other advanced tech for manufacturing and materials 6 Clinical research for the validation of diagnosis and biomakers 8 Corporate finance services DCC MANAGEMENT 0

It was followed by Greener and more integrated transport, and Clinical research.

12 SME Instrument Phase (Oct 0) success rate Topic breakdown The Phase success rate statistics after round of beneficiaries is slightly different than Phase, with Open Disruptive Innovation showing a different positioning in this ranking. At the same time, space research shows the highest success rate by far. The nd round of beneficiaries should be waited for more relevant conclusions about Phase vs Phase differences. Phase success rate (October 0) topic breakdown 6.6% 6.6%.% Eco Innovation and sustainable raw material supply.%.%.% 6.6% Nanotech, or other advanced tech for manufacturing and materials.0% Clinical research for the validation of diagnosis and biomakers.8%.9% 9.% Corporate finance services DCC MANAGEMENT 0

The nd round of beneficiaries should be waited for more relevant conclusions about Phase vs Phase differences. Phase success rate (October 0) topic breakdown 6.6%

European Research Council

European Research Council ERC Starting Grant Outcome: Indicative statistics Reproduction is authorised provided the source ERC is acknowledged ERCEA/JH. ERC Starting Grant: call Submitted and selected proposals by domain Submitted